Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, enabling its marketing as a generic drug in …
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original application for Esomeprazole Magnesium from Aurobindo Pharma Limited, adding a generic esomeprazole magnesium produ…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: The Effect of Using Virtual Reality Glasses on Post-Care Pain and Comfort Level in Intensive Care Patients [NA]
This document reports the completion of a clinical trial evaluating whether virtual reality glasses reduce post-care pain and improve comfor…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A [Phase 1]
Phase 1 study comparing pharmacokinetic/pharmacodynamic characteristics and safety between AD-120 and AD-120A in gastroesophageal reflux dis…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Role of ARMA in Selective Subset of Refractory GERD Patients. [NA]
This clinical trial evaluated the role of ARMA in a selective subset of patients with refractory gastroesophageal reflux disease and has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
A post-market registry study evaluating the RefluxStop device for gastroesophageal reflux disease is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-04-01Clinical Trial Update: Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC [Phase 3]
A Phase 3 trial comparing esomeprazole with sodium bicarbonate versus esomeprazole alone for gastroesophageal reflux disease has been withdr…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s pantoprazole sodium delayed-release granules as an original generic pantoprazole product (ANDA 217458) for aci…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for pantoprazole sodium injection, adding a new generic injectable panto…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pantoprazole Sodium from Aurobindo Pharma Limited, making a generic pantoprazole available. The pr…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux [NA]
Clinical trial comparing ondansetron to metoclopramide in infants with gastroesophageal reflux has completed, with reported efficacy and saf…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Barrett's Esophagus in Patients with GERD [NA]
A clinical trial at Assiut University is evaluating Barrett's esophagus in patients with gastroesophageal reflux disease and is currently no…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily [Phase 1]
Phase 1 study evaluating vonoprazan concentrations in breast milk of healthy lactating women given 20 mg once daily or 20 mg twice daily; re…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
A prospective study evaluating pH-impedance tracings per the Wingate consensus and their impact on Gastroesophageal reflux disease classific…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study [Phase 3]
Phase 3 clinical trial evaluating Compound Sodium Alginate Double Action Chewable Tablet for symptomatic relief in gastroesophageal reflux d…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Esophageal pH-MII Duration: 12 or 24 Hours?
A clinical trial comparing 12-hour versus 24-hour esophageal pH-impedance monitoring for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
An observational clinical trial is currently recruiting to determine the prevalence and natural history of functional gastrointestinal disor…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: EFFICACY OF INSPIRATORY MUSCLE TRAINING ASSOCIATED WITH MANUAL TECHNIQUES IN INDIVIDUALS WITH GERD [NA]
A planned clinical trial to assess whether inspiratory muscle training with manual techniques improves outcomes in individuals with gastroes…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's esomeprazole magnesium for delayed-release oral suspension via an original ANDA, confirming b…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals' esomeprazole magnesium delayed-release oral suspension via an original application, providing a generi…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: Therapeutic Effect of Vonoprazan Versus Dexlansoprazole in Treatment of Gastroesophageal Reflux Disease [Phase 4]
A Phase 4 trial comparing vonoprazan with dexlansoprazole for gastroesophageal reflux disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Laparoscopic Total Left-sided Surgical Approach Versus Traditional Bilateral Surgical Approach for Hiatal Hernia [NA]
A completed clinical trial comparing a laparoscopic total left-sided approach with the traditional bilateral approach for hiatal hernia, eva…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Endoscopic Conversion of Sleeve Gastrectomy to Single Anastomosis Sleeve-ileal Bypass (SASI) for Gastroesophageal Reflux (GERD), Primary and Secondary Non-responder. [NA]
Clinical trial update for endoscopic conversion of sleeve gastrectomy to SASI to treat gastroesophageal reflux disease in primary and second…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Effect of Long-Term Electrical Stimulation on LES Pressure and Esophageal Acid Exposure in Patients With GERD [NA]
This clinical trial update reports on the completed study of long-term electrical stimulation of the lower esophageal sphincter in GERD pati…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study) [NA]
This is a single-center randomized, sham-controlled trial evaluating argon plasma coagulation endoscopic therapy for gastroesophageal reflux…